Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus

Rheumatology International

Volumn 33, Issue 10, 2013, Pages 2591-2596

  Tahmasebi, Zahra ^a   Akbarian, Mahmoud ^a   Mirkazemi, Sedigheh ^a   Shahlaee, Abtin ^a,b   Alizadeh, Zahra ^a   Amirzargar, Ali Akbar ^b   Jamshidi, Ahmad Reza ^a   Ghoroghi, Shima ^a   Poursani, Shiva ^a   Nourijelyani, Keramat ^b   Mahmoudi, Mahdi ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Interleukin 1 gene cluster; Single nucleotide polymorphism; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXON; FEMALE; GENE CLUSTER; GENE FLOW; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOTE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-1; IRAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-1;

EID: 84885368983     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2784-2     Document Type: Article

References (27)

1. Magnusson V, Nakken B, Bolstad AI, Alarcon-Riquelme ME (2001) Cytokine polymorphisms in systemic lupus erythematosus and Sjogren's syndrome. Scand J Immunol 54(1-2):55-61
2. Ronnblom L, Elkon KB (2010) Cytokines as therapeutic targets in SLE. Nat Rev Rheumatol 6(6):339-347. doi: 10.1038/nrrheum.2010.64
3. Rus V, Atamas SP, Shustova V, Luzina IG, Selaru F, Magder LS, Via CS (2002) Expression of cytokine - and chemokine - related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin immunol 102(3):283-290. doi: 10.1006/clim.2001.5182
4. Tayal V, Kalra BS (2008) Cytokines and anti-cytokines as therapeutics-an update. Eur J Pharmacol 579(1-3):1-12. doi: 10.1016/j.ejphar.2007.10.049
5. Scuderi F, Convertino R, Molino N, Provenzano C, Marino M, Zoli A, Bartoccioni E (2003) Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus. Autoimmunity 36(2):71-77
6. Suzuki H, Takemura H, Kashiwagi H (1995) Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity. Arthritis Rheum 38(8):1055-1059
7. Ferrante L, Opdal SH, Vege A, Rognum TO (2010) IL-1 gene cluster polymorphisms and sudden infant death syndrome. Hum Immunol 71(4):402-406. doi: 10.1016/j.humimm.2010.01.011
8. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87(6):2095-2147
9. Dinarello CA (2002) The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 20(5 Suppl 27):S1-13
10. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. doi: 10.1002/1529-0131(199709)40:9<1725:AID-ART29>3.0.CO;2-Y
11. Roe B, Crabtree J, Khan A (1995) Methods for DNA isolation. Part III. Protocols for recombinant DNA isolation, cloning, and sequencing [Internet edition] Norman, OK: University of Oklahoma: 2488-2498
12. Dripps DJ, Verderber E, Ng RK, Thompson RC, Eisenberg SP (1991) Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils. J Biol Chem 266(30):20311-20315
13. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91(4):403-404
14. Huang CM, Wu MC, Wu JY, Tsai FJ (2002) Interleukin-1 receptor antagonist gene polymorphism in chinese patients with systemic lupus erythematosus. Clin Rheumatol 21(3):255-257
15. D'Alfonso S, Rampi M, Bocchio D, Colombo G, Scorza-Smeraldi R, Momigliano-Richardi P (2000) Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum 43(1):120-128. doi: 10.1002/1529-0131(200001)43:1<120:AID- ANR15>3.0.CO;2-3
16. Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW (1994) Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37(9):1380-1385
17. Suzuki H, Matsui Y, Kashiwagi H (1997) Interleukin-1 receptor antagonist gene polymorphism in Japanese patients with systemic lupus erythematosus. Arthritis Rheum 40(2):389-390
18. Danis VA, Millington M, Huang Q, Hyland V, Grennan D (1995) Lack of association between an interleukin-1 receptor antagonist gene polymorphism and systemic lupus erythematosus. Dis Markers 12(2):135-139
19. Sturfelt G, Roux-Lombard P, Wollheim FA, Dayer JM (1997) Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus. Br J Rheumatol 36(12):1283-1289
20. Tsai LJ, Lan JL, Lin CY, Hsiao SH, Tsai LM, Tsai JJ (2006) The different expression patterns of interleukin-1 receptor antagonist in systemic lupus erythematosus. Tissue Antigens 68(6):493-501. doi: 10.1111/j.1399-0039.2006. 00704.x
21. Parks CG, Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP (2004) Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis 63(1):91-94
22. Tsai LJ, Hsiao SH, Tsai JJ, Lin CY, Tsai LM, Lan JL (2009) Higher genetic susceptibility to inflammation in mild disease activity of systemic lupus erythematosus. Rheumatol Int 29(9):1001-1011. doi: 10.1007/s00296-009-0900-0
23. Huang CM, Wu MC, Wu JY, Tsai FJ (2002) Lack of association of interleukin-1 beta gene polymorphisms in Chinese patients with systemic lupus erythematosus. Rheumatol Int 21(5):173-175
24. Camargo JF, Correa PA, Castiblanco J, Anaya JM (2004) Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun 5(8):609-614. doi: 10.1038/sj.gene.6364133
25. Karasneh J, Hajeer AH, Barrett J, Ollier WE, Thornhill M, Gul A (2003) Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease. Rheumatology (Oxford) 42(7):860-864. doi: 10.1093/rheumatology/keg232R
26. Alayli G, Aydin F, Coban AY, Sullu Y, Canturk F, Bek Y, Durupinar B, Canturk T (2007) T helper 1 type cytokines polymorphisms: association with susceptibility to Behcet's disease. Clin Rheumatol 26(8):1299-1305. doi: 10.1007/s10067-006-0503-z
27. Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, Colombo M, Napoleone E, Amore C, D'Orazio A, Padovani A, de Gaetano G, Giannuzzi P, Donati MB (2005) Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 25(1):222-227. doi: 10.1161/01.ATV. 0000150039.60906.02